Practical Management of Thyroid Cancer
A Multidisciplinary Approach
Buch in deiner Nähe kaufen
Beschreibung
Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.
It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRK gene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.
The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists.
Draws on international experience across many disciplines offering a practical approach to the topic
Examines the latest advances in surgical and non-surgical management
Discusses molecular studies and translational research and how they have transformed the diagnosis and management of thyroid cancer
Addresses current challenges and areas of controversy such as low risk thyroid cancer and papillary microcarcinoma
Covid-19 pandemic and thyroid cancer -- lessons learnt Artificial intelligence in thyroid cancer Genomics based platform trials, tumour agnostic drugs
Autor*in
Ujjal K. Mallick
Themen in »Practical Management of Thyroid Cancer«
Thyroid Cancer COVID-19 Pandemic and Thyroid Cancer Recent Breakthroughs in Management New Genomics and Master Protocol Trials, Tumour Agnostic Drugs Immune Microenvironment and Immunotherapy Artificial Intelligence in Thyroid Cancer Circulating Tumour Cells and Free DNA Telemedicine